Substance Use Disorder M&A Market During 1H 2024
The substance use disorder (SUD) specialty is often the most active submarket in the Behavioral Health Care (BHC) sector, and the first half of 2024 was no exception. According to data captured in the LevinPro HC database, 10 SUD deals were announced during the first six months of 2024, making up about 28% of all BHC deals announced during that time. 1H 2024 activity mirrored the activity witnessed in the first half of 2023, when SUD deals comprised 27% of all BHC deals announced. This consistency reflects sustained investor interest in the SUD treatment space. However, a comparison to the first half of 2022 (36% of BHC deals) and 2021 (34% of BHC deals), when SUD deal totals hit 21... Read More »
Specialized Dental Partners Acquires McMurtrey Endodontics
On July 3, Specialized Dental Partners (SDP) announced that it acquired its second Colorado practice of 2024 with the acquisition of McMurtrey Endodontics. McMurtrey Endodontics operates out of one location in Westminster, Colorado. In addition to general dentistry, it provides endodontic services. According to its website, it is run by two providers. A portfolio company of private equity group Quad-C Management, SDP is a leading specialty dental service organization that provides comprehensive support services to endodontic specialists across the United States. According to data captured in the LevinPro HC database, this acquisition represents the 260th Physician Medical... Read More »
ACG NY Healthcare Conference Recap
Last week, the LevinPro HC team ventured to the upper east side of Manhattan to attend the 16th Annual ACG New York Healthcare Conference. It’s usually a short (but productive) evening of networking and honest conversations around the healthcare M&A market and private equity, and this year was no different. The keynote speaker was Jonathon Bush, Founder and CEO of Zus Health, a digital health platform offering care-coordination programs and analytics for providers. If Mr. Bush’s name rings a bell, he was the co-founder of athenahealth, another eHealth company offering a suite of electronic health record and patient engagement services. Moderated by Andrew... Read More »
PE-Backed Riverpoint Medical Acquires CP Medical
Riverpoint Medical announced that it has completed the acquisition of CP Medical. Riverpoint is a portfolio company of Arlington Capital Partners, a Washington, D.C.-area private investment firm specializing in government-regulated industries. CP Medical is a Norcross, Georgia-based manufacturer of surgical solutions, specializing in products for wound closure as well as for specialty surgical applications. CP Medical also manufactures a comprehensive portfolio of private-label sutures and wound closure products, sold through a global network of distributors, for the veterinary and human medical market. Headquartered in Portland, Oregon, Riverpoint Medical is a developer, designer and... Read More »
NMS Capital-Backed Flourish Research Partners With ENCORE Research Group
NMS Capital portfolio company Flourish Research announced that it has partnered with ENCORE Research Group, headquartered in Fleming Island, Florida. ENCORE Research Group is a clinical research organization with eight locations across Northern Florida. Since its inception in 1997, ENCORE has conducted more than 3,200 clinical trials across more than 50 therapeutic areas. ENCORE has expertise across multiple therapeutic areas including cardiology, metabolic, neuroscience, gastroenterology, orthopedics, autoimmune, pediatrics, early phase and infectious disease. Based in New York City, Flourish Research is a fully integrated clinical trial organization in North America. The company has... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
